A new peer-reviewed study from the Environmental Working Group finds that advanced PFAS filtration systems not only remove toxic "forever chemicals" from drinking water but also significantly reduce other harmful contaminants. These include cancer-linked disinfection byproducts, agricultural nitrates, and heavy metals like arsenic and uranium. The study, published in ACS ES&T Water, analyzed data from 19 U.S. utilities and the EPA’s national monitoring program, showing that technologies like granular activated carbon, ion exchange, and reverse osmosis offer broader public health benefits than previously recognized.

An unmet need exists for effective therapies to lower triglyceride levels in patients with residual cardiovascular risk despite optimal lipid-lowering therapies.    

The ESSENCE-TIMI 73b trial investigated the efficacy and safety of the apolipoprotein C-III RNA-targeting medicine, olezarsen, in patients with moderate hypertriglyceridaemia and elevated cardiovascular risk.  

Monthly olezarsen injections significantly reduced triglyceride levels by approximately 60% at 6 months vs. placebo and more than 80% of patients achieved normal triglyceride levels with olezarsen at 12 months.